Equity

MDSKX

iShares Russell 2000 Small-Cap Index Fund

Overview

Loading

Performance

Performance

Growth of Hypothetical $10,000

Performance chart data not available for display.
View full chart

Distributions

Record Date Ex-Date Payable Date
View full table
  1y 3y 5y 10y
19.31 -0.36 7.83 7.30
Benchmark (%) 19.71 -0.10 8.10 7.58
Morningstar Category Avg. (%) 18.93 3.43 9.33 7.66
Morningstar Ranking 294/610 529/584 430/552 257/384
Morningstar Quartile 2 4 4 3
Lipper Category Avg. (%) 19.10 3.99 9.38 7.58
Lipper Ranking 524/1007 880/969 726/905 411/667
Lipper Quartile 3 4 4 3
  YTD 1m 3m 1y 3y 5y 10y
5.10 3.57 5.10 19.31 -1.07 45.76 102.29
Benchmark (%) 5.18 3.58 5.18 19.71 -0.31 47.65 107.61
Morningstar Category Avg. (%) 5.66 3.84 5.66 18.93 10.65 56.23 109.29
Lipper Category Avg. (%) 5.85 4.25 5.85 19.10 12.85 57.54 109.60
  2019 2020 2021 2022 2023
Total Return (%) 25.20 19.66 14.38 -20.57 16.60
Benchmark (%) 25.52 19.96 14.82 -20.44 16.93
Morningstar Category Avg. (%) 23.75 10.99 24.19 -16.24 16.18

Performance is shown after deduction of ongoing charges. Any entry and exit charges are excluded from the calculation.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.

Key Facts

Key Facts

Net Assets as of Apr 12, 2024 $202,242,179
Net Assets of Fund as of Apr 12, 2024 $2,677,088,462
Share Class launch date Apr 09, 1997
Asset Class Equity
Benchmark Index Russell 2000 Index (Gross Total Return)
Distribution Frequency Annual
Morningstar Category Small Blend
Lipper Classification Small-Cap Core Funds
CUSIP 09253F705
Max Offer Price as of Apr 12, 2024 $22.72
Open to New Investors Yes
Turnover Percent in the Annual Report 38.00%

Portfolio Characteristics

Portfolio Characteristics

Number of Holdings as of - -
P/E Ratio as of Jun 30, 2023 0.00
P/B Ratio as of Jun 30, 2023 0.00
Alpha (3y) as of Mar 31, 2024 -0.02
Average Market Cap (Millions) $ 0.0 M
R-Squared (3y) 100.00
Fund Standard Deviation (3y) as of Mar 31, 2024 21.37
Beta (3y) as of Mar 31, 2024 1.00
Best 3-Month Return Over the Last 3 Years 3 months ending Jan 31, 2024 17.48%
Worst 3-Month Return Over the Last 3 Years 3 months ending Jun 30, 2022 -17.23%
This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section above.

Fees

Fees

as of current prospectus
Gross Expense Ratio 0.40%
Net Expense Ratio 0.37%

Net Expense Ratio excluding Investment Related Expenses is 0.37%

  • Acquired Fund Fees and Expenses 0.00%
  • Interest expense 0.00%

Ratings

Ratings

Lipper Leader

 
 
 
Overall Lipper Leaders ratings based on an equal-weighted average of percentile ranks for each measure over 3-, 5-, and 10-year periods (if applicable) and do not take into account the effects of sales charges for these categories (Consistent Return, Preservation, Total Return, Expense, and Tax Efficiency) as of Mar 31, 2024 out of 972, 12,478, 969, 258 and 969 Funds, respectively in Lipper's Small-Cap Core Funds classification.

Holdings

Holdings

as of Sep 30, 2020
Name Weight (%)
PENN NATIONAL GAMING INC 0.58
SUNRUN INC 0.48
CAESARS ENTERTAINMENT INC 0.41
MYOKARDIA INC 0.37
NOVAVAX INC 0.35
Name Weight (%)
IRHYTHM TECHNOLOGIES INC 0.35
LHC GROUP INC 0.34
MIRATI THERAPEUTICS INC 0.33
CHURCHILL DOWNS INCORPORATED 0.33
MOMENTA PHARMACEUTICALS INC. 0.33
Name Market Value Weight (%) Shares
Holdings are subject to change. Fund holdings and allocations shown are unaudited, and may not be representative of current or future investments. Holdings shown should not be deemed as a recommendation to buy or sell securities. The user relies on this data at its own risk and neither BlackRock nor any other party makes any representations or express or implied warranties (which are expressly disclaimed) nor shall they incur any liability for any errors or omissions in the data.

Exposure Breakdowns

Exposure Breakdowns

as of Sep 30, 2020

% of Market Value

Type Fund Benchmark Net
as of Sep 30, 2020

% of Market Value

Type Fund Benchmark Net
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

Paul Whitehead
Paul Whitehead
Jennifer Hsui
Jennifer Hsui
Portfolio Manager

Literature

Literature

Loading fund documents...
No documents found
Checkout {{ translations['submit'][selectedAction] }} {{ responseMessage }} {{ warningMessage }} You have previously requested to be opted out of all BlackRock Literature Services emails. To subscribe, you must opt back in.